Skip to main content
editorial
. 2022 Sep 1;11(4):1457–1473. doi: 10.1007/s40120-022-00401-4

Fig. 3.

Fig. 3

Kaplan–Meier estimate of disability worsening confirmed at A 3 months or B 6 months during treatment with ofatumumab or teriflunomide [64]. CI confidence interval.

From Hauser et al. [64]. Copyright© 2020 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society